3,5-Dimethoxy-4-hydroxy myricanol attenuated oxidative stress-induced toxicity on cardiomyoblast cells

Area of Science:

• Biochemistry
• Cardiovascular Research
• Cell Biology

Background:

• Myocardial ischemia, a primary cause of ischemic heart disease, is exacerbated by oxidative stress.
• Antioxidant therapies are explored for preventing myocardial ischemia injury due to the critical role of oxidative stress.

Purpose of the Study:

• To investigate the protective effects of 3,5-dimethoxy-4-hydroxy myricanol (DHM) against oxidative stress-induced cytotoxicity in H9c2 cells.
• To elucidate the underlying mechanisms of DHM's protective actions, focusing on oxidative stress and inflammatory pathways.

Main Methods:

• H9c2 cells were subjected to oxidative stress.
• Oxidative stress and inflammatory markers were assessed using H2DCFDA fluorescence, ELISA, real-time PCR, and Western blot.
• Protein expression levels of heme oxygenase-1 (HO-1), Nrf2, MAPKs, and NF-κB were analyzed.

Main Results:

• DHM demonstrated significant inhibitory effects against H9c2 cell damage induced by oxidative stress.
• DHM treatment led to decreased oxidative stress by up-regulating HO-1 and Nrf2 protein expression.
• DHM inhibited inflammatory responses by down-regulating the protein expression of MAPKs and NF-κB.

Conclusions:

• DHM exhibits protective activities against oxidative stress-induced cell damage in a cardiac cell model.
• The protective mechanisms involve the reduction of oxidative stress and the inhibition of inflammatory responses.
• DHM shows potential as a therapeutic agent for myocardial ischemia treatment.